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Aquaglyceroporins (AQPs) are membrane proteins that function in osmoregulation and the 
uptake of low molecular weight solutes, in particular glycerol and urea. The AQP family is 
highly conserved, with two major subfamilies having arisen very early in prokaryote 
evolution and retained by eukaryotes. A complex evolutionary history indicates multiple 
lineage-specific expansions, losses and not uncommonly a complete loss. Consequently, 
the AQP family are highly evolvable and have been associated with significant events in 
life on Earth. In the African trypanosomes a role for the AQP2 paralog, in sensitivity to two 
chemotherapeutic agents, pentamidine and melarsoprol, are well established, albeit with 
the mechanisms for cell entry and resistance unclear until very recently. Here we discuss 
AQP evolution, structure and mechanisms by which AQPs impact drug sensitivity, 
suggesting that AQP2 stability is highly sensitive to mutation while serving as  the major 








Aquaglyceroporins (AQPs) were first identified in the 1990s as membrane proteins with 
functions in osmoregulation and the translocation of low molecular weight solutes, 
including glycerol and urea (Preston et al., 1992). In humans, dysfunction is associated 
with multiple cancers, kidney disease, oedema and other pathologies (King et al., 2004; 
Yool et al., 2010; Shi et al., 2012). AQPs have an evolutionarily broad representation, 
being found in most pro- and eukaryotic taxa and they retain a conserved architecture 
encompassing six hydrophobic domains. This structure is in turn derived through an 
internal duplication from a primordial protein with three membrane-spanning helice, 
reflected in the presence of two NPA (Asn-Pro-Ala) boxes that are involved in channel 
functions. Both the N- and C-termini face the cytoplasm (Figure 1) and sequence and 
architectural conservation indicates vertical descent. Consequently at least one 
mechanism for the control of water (and solute) passage across biological membranes 
arose very early in the history of life (Ishibashi et al., 2020). However, AQPs are not 
present in all taxa, for example the bacterial phyla Fibrobacteres and Lentisphaerae, as 
well as some parasites and extremophiles. As AQPs can also be deleted in some 
eukaryotes, for example immortalised mammalian cells and trypanosomatids (Jeacock et 
al., 2017; Calvanese et al., 2018) it is clear that AQPs are non-essential, at least under 
some circumstances. Control of osmolarity therefore likely utilises additional mechanisms 
in both pro- and eukaryotes. Below we will consider initially the evolution and origins of 
AQP paralogs in protists and then the uncovering of drug-related functions in 
trypanosomes.  
 
Evolution, functions and roles in protists 
The evolution of the AQP family is surprisingly complex and at least three subfamilies with 
apparently distinct functions are recognised. These include AQPs able to translocate 
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glycerol, others that only uptake water and a final third group, the superAQPs, that arose 
late in evolution. This latter subfamily is frequently intracellular, indicating a distinct 
function from the other members of the AQP family, which are usually located at the 
surface in most cells (Ishibashi et al., 2011), and are only found in metazoa. Significantly, 
the two ancestral forms are clearly differentiated in all prokaryotes, indicating an origin 
dating back to an early period of cellular life (Tong et al., 2019). The number of AQP 
paralogs in different species is highly variable, with land plants and vertebrates having the 
largest repertoires, as is the case for many other protein families.  
 There has been a considerable degree of expansion and contraction within specific 
lineages, or ‘churning’, with the result that functional differentiation between paralogs is 
difficult to predict (Ishibashi et al., 2020). Interestingly, in mussels (molluscs) there is 
evidence that expansion of AQP paralogs correlates with freshwater colonisation events 
and hence facilitating adaptation to decreased environmental salinity (Calcino et al., 2019). 
Similar events may have facilitated tetrapod colonisation of land habitats where 
desiccation is a considerable challenge (Finn et al., 2014) and underscores the importance 
of AQP evolution to life history. 
 In unicellular eukaryotes the number of AQP paralogs is comparatively small when 
compared with multicellular organisms and it has been proposed that the numbers of AQP 
paralogs are correlated somewhat with environmental complexity (von Bülow and Beitz, 
2015). Most protist AQPs appear to be the more permissive glycerol-translocating forms 
that facilitate the uptake of solutes and waste compounds in addition to water. The free-
living amoeba Amoeba proteus expresses a single AQP that is associated with the 
contractile vacuole (Nishihara et al., 2012), but by contrast there are four AQP paralogs in 
the social amoeba Dictystellium discoidium, two of which are constitutively expressed and 
the remainder stage specific. Although there is evidence for roles in differentiation, none of 
the D. discoidium AQPs are exclusively water permeable and hence functions are not 
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completely clear (Von Bülow et al., 2012). In the parasites Plasmodium falciparum and 
Toxoplasma gondii, each have a single AQP (Figure 2) and this minimal repertoire may 
reflect intracellular life cycles and a more constant environment, albeit with considerable 
levels of complexity and differentiation events during life cycle progression, particularly for 
P. falciparum.  
 Amongst the kinetoplastids, Leishmania major has five AQPs, although only AQP1 
has been studied in any detail. LmAQP1 is a wide permeability form localised on the 
flagellum and regulated by MAP kinase (Figarella et al., 2007; Mandal et al., 2012; Sharma 
et al., 2015). The remaining L. major AQPs are less well uncharacterised, but at the 
sequence level more closely resemble the plant tonoplast intrinsic protein (TIP) AQP 
subclass. Four of the five AQP genes in L. donovani retain canonical gating motifs, but in 
one paralog this is mutated to NPM-NPA. All four of the conventional AQPs are suggested 
as intracellular as is the case for the TIP AQPs of plants, but significantly LdAQP1 is likely 
to permit translocation of large solutes (Biyani et al., 2011). Antimonial-containing drugs 
remain a first line treatment against Leishmania in many parts of the world (Field et al., 
2017) and in laboratory derived strains of L. mexicana AQP1 can restore antimonial 
uptake to resistant cells (Marquis et al., 2005). No obvious genome level changes to gene 
copy number or sequence accompany resistance but is potentially a post-transcriptional 
modulation of AQP1 mRNA level. Changes to expression of AQP1 have been 
demonstrated in multiple species where resistance was derived in the laboratory (Lin et al., 
2008; Barrera et al., 2017). However, it is also clear that there is a less compelling case for 
association of altered AQP1 expression and drug resistance in clinical isolates. 
 The American trypanosome, Trypanosoma cruzi also has four TIP-like AQPs, 
representing the entire repertoire in that organism and these are associated with the 
contractile vacuole and acidocalcisomes (Montalvetti et al., 2004). Trypanosoma brucei 
has three AQPs; AQP1 is shared with other kinetoplastida, while AQP2 and AQP3 arose 
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from a recent gene duplication in the African trypanosome lineage and remain contiguous. 
 In addition to interactions between trans-membrane domains, two major selectivity 
filters restrict the molecular weights and properties of the solutes being translocated by 
AQPs and that can effectively pass through the central pore; these are the ar/R and 
NPA/NPA motif (Figure 1) (Beitz, 2005; Baker et al., 2013; Verkman et al., 2014; Munday 
et al., 2015; Fairlamb and Horn, 2018). T. brucei AQP1 and AQP3 display the internal 
arrangements in the protein pore observed in canonical AQPs, including the canonical 
“NPA” within two half α-helices and a narrower “aromatic/arginine” (ar/R) motif (Beitz, 
2005). Interestingly, TbAQP2 does not retain this canonical configuration, displaying an 
unconventional “NPS/NSA” filter motif and rearrangement in the ar/R motif that is replaced 
by a neutral leucine at position 264 (L264), followed by aliphatic, rather than aromatic, 
residues (A88, I110, V249 and L258), which are equivalent to the “IVLL” motif observed in 
the selectivity pore of canonical AQPs (de Groot and Grubmuller, 2001; Baker et al., 2013; 
Quintana et al., 2020). These structural features indicate that TbAQP2 can accommodate 
larger solutes through the selectivity pore (Uzcategui et al., 2004). 
 These examples demonstrated that AQP evolution is highly plastic, with the 
creation of additional paralogs, facilitating altered specificity. Hence, the AQP family 
contributes to surviving environmental complexity and exploitation of new ecological 
niches, with considerable impact to the life history of the earth. However, the absence of 
AQPs from many lineages or a genetic demonstration of essentially in many organisms 
serves to underscore the challenges remaining for the full understanding of AQP function. 
 
TbAQP2 and multidrug resistance 
The treatment of sleeping sickness relies on drugs to clear first- or second-stage 
infections, and the choice of drug depends on the capacity to penetrate the blood-brain 
barrier (BBB) (Denise and Barrett, 2001; Steverding, 2010; Fairlamb and Horn, 2018). Of 
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these, pentamidine and melarsoprol represent two of the most potent drugs currently used 
to treat first and second stage disease, respectively, displaying low nanomolar 50%-
effective growth-inhibitory concentration (EC50) (Denise and Barrett, 2001; Bray et al., 
2003; Barrett et al., 2007; Fairlamb and Horn, 2018). Pentamidine, an aromatic diamidine, 
is used to treat first stage (haemolymphatic stage) T. gambiense HAT (Denise and Barrett, 
2001; Barrett et al., 2007; Baker et al., 2013). This compound binds nucleic acids with high 
affinity, leading to accumulation by, and ultimately destruction of, the kinetoplast (Mathis et 
al., 2006; Baker et al., 2013; Gould and Schnaufer, 2014; Al-Horani et al., 2019; Kennedy 
and Rodgers, 2019). However, pentamidine is unable to reach the central nervous system 
(CNS), in part due to its high affinity interactions with serum proteins, charge and relatively 
high retention in tissues and is therefore ineffective for the treatment of second stage 
meningoencephalic HAT (Barrett et al., 2007; Maclean et al., 2012). Melarsoprol, on the 
other hand, is an arsenical compound used for the treatment of second stage HAT, 
including T. rhodesiense HAT (Fairlamb et al., 1989; Keiser et al., 2000; Field et al., 2017).  
This compound is thought to be metabolised to melarsen oxide prior to uptake by African 
trypanosomes, leading to the formation of a stable adduct with trypanothione known as 
Mel T (Burri et al., 1993, 1994; Fairlamb and Horn, 2018).  Melarsoprol penetrates the 
BBB comparatively more effectively than pentamidine, reaching the minimum 
concentration required for parasite clearance in the CNS (Mäser et al., 1999; Stewart et 
al., 2010). Melasoprol also displays reactive encephalopathy in ~10% of patients, which is 
frequently fatal (Fairlamb and Horn, 2018).  
 Given the limited repertoire of drugs available for treatment it is perhaps not 
surprising that resistance to these compounds has been frequently observed in endemic 
countries. Indeed, diamidine-arsenical cross-resistance was initially reported in the 1940s, 
suggesting that mechanisms of uptake and/or action were common to these otherwise 
divergent chemical compounds, but with the molecular details poorly understood. The 
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identification of the pentamidine/melarsoprol transporter has been a serendipitous 
process. Initial studies in cross-resistance in laboratory strains (Bernhard et al., 2007; 
Bridges DJ, Gould MK, Nerima B, Mäser P, Burchmore RJ, 2007; Graf et al., 2015a) and 
field isolates (Shahi et al., 2002; Alsford et al., 2012) from relapsed patients identified the 
gene encoding for the purine transporter responsible for drug uptake as Trypanosoma 
brucei adenosine transporter 1 (TbAT1). In addition to TbAT1, the high-affinity pentamidine 
transporter (HAPT1) (Bernhard et al., 2007) as well as the ATP-binding cassette 
transporter MRPA (Baker et al., 2012) were also proposed to mediate drug resistance by 
various mechanisms, but neither explained the drug resistance levels observed in field 
isolates (Baker et al., 2013).  
 Using genome-wide RNAi-mediated genetic screening and functional assays, the 
locus encoding the closely related AQP2 and AQP3 was identified as a bona fide hit for 
pentamidine/melarsoprol cross-resistance (Graf et al., 2015b). Further biochemical and 
genetic manipulation studies demonstrated that deletion of AQP2, but not AQP3, led to a 
significant increase in the EC50 of both compounds, mirroring the behaviour observed in 
previously generated laboratory strains and field isolates (Munday et al., 2014; Graf et al., 
2015b; Song et al., 2016). Other observations such as localisation to the flagellar pocket in 
the bloodstream form (Munday et al., 2014; Graf et al., 2015b; Song et al., 2016; Quintana 
et al., 2020) , as well as the unusual pore structure discussed above, led to the hypothesis 
that pentamidine and melarsoprol are likely to interact with high affinity to AQP2 located in 
the flagellar pocket (Alghamdi et al., 2020), posing the question of how these compounds 
are internalised and also the mechanisms for resistance. 
 
Endocytosis or membrane uptake: competing models for drug entry 
Suggesting that the role of a channel protein is not the primary mechanism for pentamidine 
to access the trypanosome cytoplasm may seem to be a straw man, but this possibility has 
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been proposed. Specifically, as AQP2 binds pentamidine with high affinity at the first 
selectivity pore, the possibility that AQP2 is a receptor for uptake by endocytosis is not 
unreasonable (Figure 2) and could act as a parallel to ISG75-mediated uptake of suramin 
(Graf et al., 2015b). This model was further supported by reports demonstrating that 
pentamidine binds AQP2 with nanomolar affinity, thus potentially acting as a highly 
selective inhibitor of AQP2 (Figure 2) (Alghamdi et al., 2020). However, consideration of 
structural features of the pore do support TbAQP2 acting as a channel for larger and more 
structurally flexible solutes including pentamidine (Petersen and Beitz, 2020). In the 
endocytosis model, ubiquitination of TbAQP2 at the flagellar pocket is central for 
subsequent ubiquitination-mediated intracellular trafficking and delivery to intracellular 
organelles such as the lysosome. Indeed, TbAQP2 forms a stable homomultimeric 
complex in the flagellar pocket where ubiquitination is likely to take place on individual 
monomers (Quintana et al., 2020).  
 The opposing membrane uptake model proposes that pentamidine, and potentially 
melarsoprol, are taken up via the intrinsic channel properties of TbAQP2. Indeed, a recent 
report demonstrates that drug permeation is possible due to a highly conserved amino 
acid motif in the central pore architecture of TbAQP2, facilitating the passage of ‘high’ 
molecular weight solutes (Alghamdi et al., 2020). This was demonstrated by TbAQP3 
mutants containing the amino acids of the selectivity pore from TbAQP2 possessing 
increased capacity for pentamidine uptake (Alghamdi et al., 2020) . Moreover, pentamidine 
permeation through TbAQP2 seems to be further aided by the intrinsic membrane 
potential and is not abrogated by partially blocking endocytic uptake (Alghamdi et al., 
2020; Quintana et al., 2020), albeit at a rate that is considerably slower than for lower 
molecular weight solutes, which in essence implies a leak in the AQP2 permeability 
barrier.  
 Concerning the likely site for pentamidine uptake, there is no evidence that 
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endocytosis or post-translational modification of AQP2 is required. Specifically, additional 
genes identified from the genome-wide RNAi screen identified a kinase and phosphatase 
for melarsoprol and pentamidine respectively, as well as one unique hypothetical each 
(Alsford et al., 2012). None of these genes have evidence for roles in ubiquitylation, 
endocytosis or trafficking in general, suggesting that translocation of drugs from the 
surface is sufficient for toxicity and that blocking ubiquitylation or endocytosis does not 
offer resistance. However, it needs to be acknowledged that a role for endocytosis that is 
overshadowed by the channel-mediated mechanism, remains a possibility.  
 
Stability and folding of TbAQP2 contribute to pentamidine resistance 
In common with most membrane proteins, AQPs undergoing translation are inserted into 
the endoplasmic reticulum through the Sec61 translocon and assisted in folding via a 
cohort of chaperones (Pitonzo and Skach, 2006). Given that most AQPs are also 
glycoproteins it is likely that the calnexin/calreticulin quality control system is involved in 
monitoring quality and rapidity of folding. Importantly, formation of homotetrameric 
complexes is important for AQP stability and the formation of heterotetrameric complexes 
has not been observed (Duchesne et al., 2002; Furman et al., 2003). The residues 
responsible for this specificity are not clear, but AQP tetramers can assemble into higher 
order quasi-crystalline arrays (Kitchen et al., 2016). Further, there are clear differences in 
the stabilities of the water and solute permeable AQP tetramers with the former exhibiting 
greater stability than the latter and likely due to features within the final two trans-
membrane domains and loops D and E (Lagrée et al., 1998; Duchesne et al., 2002; Buck 
et al., 2007; Kitchen et al., 2016), albeit with the functional consequences, if any, unclear. 
Significantly the folding pathway is not identical for all AQPs, being controlled at least 
partly by sequences within the second trans-membrane domain (Carrington et al., 2010). 
Finally, mammalian AQPs are both phosphorylated and ubiquitylated, with at least the 
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latter contributing to protein turnover, endocytosis and quality control (Kamsteeg et al., 
2006; Mandal et al., 2012; Sharma et al., 2015; Quintana et al., 2020). While it is most 
likely that similar pathways operate in trypanosomes, with direct evidence for ubiquitylation 
and most of the relevant folding chaperones present, the precise mechanisms of AQP 
maturation, at least in African trypanosomes, remain to be investigated in detail (Field et 
al., 2010; Tiengwe et al., 2016a; b).  
 To understand folding, stability and trafficking of AQP2 in T. brucei we examined 
sequence-dependence and trans-membrane domain exchange designed to mimic natural 
AQP2/3 chimeras expressed in a triple null background (Jeacock et al., 2017; Quintana et 
al., 2020). TbAQP2 forms both tetramers and tetramers of tetramers and is degraded in 
the lysosome by a ubiquitin-dependent process (Figure 2) (Quintana et al., 2020). 
Attempts to influence ubiquitination by mutating cytoplasmic lysine residues unexpectedly 
reduce stability rather than preventing lysosomal targeting (Quintana et al., 2020). This is 
due to reduced folding and tetramerization efficiency, which triggers ER-associated 
degradation, indicating a failure to complete quality control (Quintana et al., 2020). 
Perhaps the most significant finding is that chimerical TbAQP2/3 proteins also lead to 
impaired folding and reduced stability (Quintana et al., 2020). This was also the case for 
constructs mimicking chimeras found in trypanosomes from patients where pentamidine 
treatment had failed. 
 Clearly rigorous quality control mechanisms operate within the ER of T. brucei, but 
with a consequence that mutations in the non-essential AQPs can render parasites 
refractory to treatment. Moreover, the instability of AQP2 is likely an underlying cause of 
pentamidine treatment failure while the production of chimeric forms is potentially a high 
frequency event and stems directly from generation of contiguous paralogs initially derived 
by gene duplication; presumably the chimeras have poor folding capability due to 
mismatch between the N- and C-terminal regions. 
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Remarkable advances to understanding mechanisms for classical therapies against 
African trypanosomes, as well as development of new drugs and the successes of public 
health programs, auger well for the control of both human and animal African 
trypanosomiasis. Remarkably, we now have considerable understanding of pentamidine 
and melarsoprol uptake as well as mechanisms for resistance. The evolutionary history of 
trypanosome AQPs reveals both how pentamidine sensitivity arose, with a specifically 
broad-spectrum AQP2, and resistance arising from recombination. Placed in context 
(Figure 3) the millennia-old relationship between trypanosomes and humans has been 
complex, with periods where one organism had the upper hand and then the other. 
Recently, humans have been in the ascendant, with case numbers having dropped 
precipitously and even exceeding the WHO roadmap predictions. Indeed, several 
countries previously considered endemic have reported no cases for several years. It can 
only be hoped that the advances made in the last decade are not eroded by the COVID-19 
pandemic, which threatens to undermine global progress on many fronts, including the 
control of infectious diseases (http://hdr.undp.org/en/2020-report). 
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Figure 1: Structure and copy number of AQP paralogs. A) Left panel: Depiction of the 
T. brucei AQP2 monomer. The trans-membrane domains are highlighted in magenta. 
Right panel: Detail of the unique NPS/NSA TbAQP2 selectivity pore. B) Left panel: Top 
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view of the proposed tetrameric structure of T. brucei AQP2 model. The lysine residues in 
position K147 and K234 are shown as spheres. Right panel: expanded view of the 
conformational change observed during TMD simulations on TMD1 and TMD3 as a result 
of the K147R mutation. Wild type TbAQP2 is shown in green. TbAQP2 displaying the 
K147R and K234R mutations is shown in light orange. Other residues important for 
intramolecular interactions between transmembrane domains (N70, D73, K142, Y151) are 
also highlighted. Mutations on these residues profoundly impair protein stability, rendering 
the parasites resistant to pentamidine and melarsoprol. (Taken from [23]). C) Number of 
clear AQP paralogs detected in representative taxa. Note that for the protists these are all 
represented by the more permissive glycerol-capable class. 
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Figure 2: TbAQP2 trafficking, assembly and pentamidine uptake. Schematic of the 
trypanosome endomembrane system, focused on the region between the nucleus and 
flagellar pocket and encompassing the mitochondrion. AQP proteins are represented as 
open colored cylinders, with the opening indicting the cell external/intracellular lumenal 
face of the molecule. Note that both ER and endosomal molecules can become 
ubiquitylated (red dot). It is most likely that pentamidine enters the cell at the cell surface 
(see text) and is then translocated into the mitochondrion to interact with the kinetoplast 
(mitochondrial genome, purple circles) but he possibility that there is a contribution from 
endocytosis of AQP; Pentamadine complexes remains a possibility. 
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Figure 3: Major events in the history of African trypanosomiasis.  Annotations above the timeline in black indicate major cultural, 
historical and management events with a bearing on trypanosomiasis. The influence on hominid evolution is inferred from impact on 
savannah ecosystems. Annotations in green indicate introduction of chemotherapeutic agents and in red emergence of resistance 
mechanisms and related advances in molecular understanding. Annotated beneath the timeline are periods of major change in the 
incidence of trypanosomiasis, in red for periods of epidemics and teal for control measures. 
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